AU2001281637A1 - Percutaneous or transcutaneous access to the interior of the body - Google Patents
Percutaneous or transcutaneous access to the interior of the bodyInfo
- Publication number
- AU2001281637A1 AU2001281637A1 AU2001281637A AU2001281637A AU2001281637A1 AU 2001281637 A1 AU2001281637 A1 AU 2001281637A1 AU 2001281637 A AU2001281637 A AU 2001281637A AU 2001281637 A AU2001281637 A AU 2001281637A AU 2001281637 A1 AU2001281637 A1 AU 2001281637A1
- Authority
- AU
- Australia
- Prior art keywords
- percutaneous
- interior
- transcutaneous access
- transcutaneous
- access
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CH2001/000499 WO2001083023A2 (en) | 2001-08-14 | 2001-08-14 | Percutaneous or transcutaneous access to the interior of the body |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2001281637A1 true AU2001281637A1 (en) | 2002-01-31 |
| AU2001281637B2 AU2001281637B2 (en) | 2007-07-26 |
Family
ID=32097380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001281637A Ceased AU2001281637B2 (en) | 2001-08-14 | 2001-08-14 | Percutaneous or transcutaneous access to the interior of the body |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1417002B1 (en) |
| JP (1) | JP2004531277A (en) |
| AU (1) | AU2001281637B2 (en) |
| CA (1) | CA2456849A1 (en) |
| DE (1) | DE50113019D1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009047774A2 (en) * | 2007-10-09 | 2009-04-16 | Transpharma Ltd. | Magnetic patch coupling |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4004298A (en) * | 1975-03-31 | 1977-01-25 | Sinai Hospital Of Detroit | Magnetically aligned releasable connector |
| US4352960A (en) * | 1980-09-30 | 1982-10-05 | Baptist Medical Center Of Oklahoma, Inc. | Magnetic transcutaneous mount for external device of an associated implant |
| JPH0763494B2 (en) * | 1986-05-21 | 1995-07-12 | ゾームド―トリース,インコーポレイティド | Implantable electromagnetic middle ear conduction type hearing aid |
| JP2601277B2 (en) * | 1987-06-29 | 1997-04-16 | 京セラ株式会社 | In vivo and external communication device |
-
2001
- 2001-08-14 DE DE50113019T patent/DE50113019D1/en not_active Expired - Lifetime
- 2001-08-14 JP JP2001579894A patent/JP2004531277A/en active Pending
- 2001-08-14 EP EP01960023A patent/EP1417002B1/en not_active Expired - Lifetime
- 2001-08-14 CA CA002456849A patent/CA2456849A1/en not_active Abandoned
- 2001-08-14 AU AU2001281637A patent/AU2001281637B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU8163701A (en) | Percutaneous or transcutaneous access to the interior of the body | |
| AU2003226217A1 (en) | Body lumen closure | |
| AU2741801A (en) | Splittable medical valve | |
| AU2002218742A1 (en) | Application of photochemotherapy for the treatment of cardiac arrhythmias | |
| AU3791601A (en) | Treatment of coal | |
| EP1270376A3 (en) | Front body structure of vehicle | |
| AU2002215772A1 (en) | Implantable neurostimulator | |
| AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
| AU2002217866A1 (en) | Geldanamycin derivatives useful for the treatment of cancer | |
| AU5487699A (en) | Adhesive compositions for the hard tissues of the human body | |
| AU2001260834A1 (en) | The treatment of herpes | |
| AU2292301A (en) | Human kinases | |
| AU2002319650A1 (en) | Defibrillators | |
| AU4998100A (en) | Methods of using percarboxylic acid or anions thereof and methods of making the same | |
| AU4989400A (en) | Stabilization of isothiazolone | |
| AU2021601A (en) | Composition for the treatment of dandruff | |
| AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
| AU2001281637A1 (en) | Percutaneous or transcutaneous access to the interior of the body | |
| AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
| AU5552400A (en) | Treatment of cancer | |
| AUPQ367699A0 (en) | Treatment of cancer | |
| AU3064800A (en) | The therapeutic use of r-warfarin as anticoagulant | |
| AU3172600A (en) | Use of vitamin c or the like for stimulating skin cell synthesis | |
| AU2002214950A1 (en) | Determination of the ability of patients to respond to tumour treatment | |
| AU2683500A (en) | Compositions for the treatment of pain |